E Cannabis Central: Most Portfolio Participants Performed Poorly This Past Week

The majority of the 25 stocks in the munKNEE.com Pure-Play Pot Stock Portfolio performed poorly for the trading week ending September 18th, going down 1.3% on the heels of a 3.1% decline the previous week and 6.9% the week before that. 15 of the constituents went DOWN and all 4 of the industry categories declined as well. The winners and losers are as follows:

Friday's Performance

This past Friday saw the portfolio go down 0.7% with 13 of the 25 stocks going down and 3 of the 4 industry categories in which they operate going down as well. Two stocks, Aurora (ACB) and Harvest Health (HRVSF), went down 5.2% and 5.0%, respectively, while Avicanna (AVCNF) was the only stock to go up more than 5% on the day (+5.8%)

Last Week's Performance

Major Winners

While 10 of the stocks in the portfolio finished the week up in price, only one went up by 10% or more, namely cbdMD (YCBD) which went up by 15.1%, and only one went up more than 5%, namely, Organigram (OGI) which went up 7.5%.

Major Losers

15 of the stocks in the portfolio (60%) finished the week down in price but none did so in excess of 10% although four constituents did go DOWN in excess of 5%, namely:

  1. Valens (VLNCF) -7.1%
  2. Charlotte's Web (CWBHF) -6.6% vs. -11.2% the previous week
  3. Aurora (ACB) -6.4% vs -18.0% the previous week and -13.3% the week before that.
  4. Greenlane (GNLN) -6.2% vs. -9.7% the previous week

The 25 munKNEE.com Pure-Play Pot Stock Portfolio includes companies doing business in 4 categories based on their primary area of focus in the cannabis industry. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:

  1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and they went down 1.2%, on average, vs. a 2.9% decline, on average, the previous week.
    • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB;; CGCAPHACRON; OGI; ROMJF and TLRY) went up 0.2% vs. a 5.8% decline, on average, the previous week.
    • the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGFAYRSFCCHWFCRLBF; CURLFGTBIFHRVSFJUSHF;  PLNHFSHWZTCNNF and TRSS) went down 2.1%, on average, vs. a 0.8% decline, on average, the previous week.
    • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went up 2.0%, on average, vs. a 9.9% decline, on average, the previous week
  2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went down 1.5%, on average, vs. a 4.8% decline, on average, the week before.
  3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went down 6.2% vs. a decline of 9.7% the previous week.
  4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went down 2.2% vs. a 6.1% decline the previous week.
1 2
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.